McClean S W, Young D S, Yonekawa W
Clin Chem. 1977 Jan;23(1):116-8.
The "EMIT" enzyme immunoassay system (Syva) that involves use of glucose-6-phosphate dehydrogenase (EC 1.1.1.49) as the enzyme label has been adapted to a fully mechanized kinetic enzyme analyzer for analysis of phenobarbital, phenytoin, and primidone. This procedure, compared with the gas-chromatographic procedure of Kupferberg [Clin. Chim. Acta 29, 283 (1970)], gave a weighted regression line--forced through the origin--of y=(1.01+/-0.04) x for phenobarbital, y=(0.95+/-0.04) x for primidone. Within-run coefficients of variation based on single determinations were 9,11, and 22% for primidone, phenobarbital, and phenytoin, respectively. Run-to-run assay CV was 6% for primidone and phenobarbital and 13% for phenytoin, based on the means of triplicate determinations of a sample with a mid-range concentration.
采用葡萄糖-6-磷酸脱氢酶(EC 1.1.1.49)作为酶标记的“EMIT”酶免疫分析系统(Syva公司)已被适配于一台全机械化动力学酶分析仪,用于分析苯巴比妥、苯妥英和扑米酮。与Kupferberg的气相色谱法[《临床化学学报》29, 283 (1970)]相比,该方法得出的加权回归线(强制通过原点)对于苯巴比妥为y = (1.01 ± 0.04)x,对于扑米酮为y = (0.95 ± 0.04)x。基于单次测定的批内变异系数,扑米酮、苯巴比妥和苯妥英分别为9%、11%和22%。基于对一个中等浓度样品进行三次重复测定的平均值,扑米酮和苯巴比妥的批间分析变异系数为6%,苯妥英为13%。